Draft rare disease therapies regulatory framework - consultation

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has opened its consultation on the Draft rare disease therapies regulatory framework.  The CoRE will be sending in a response, and notes that patients and the general public are also invited to respond.

For more, see https://www.gov.uk/government/consultations/draft-rare-disease-therapies-regulatory-framework 

The consultation closes at 11:59pm on 30 July 2026 (UK time)